





Abstract—Patients with progressive nonfluent aphasia (PNFA) can become
mute early in the course of the disease. Voxel-based morphometry showed that
PNFA is associated with left anterior insula and inferior frontal atrophy. In
PNFA with early mutism, volume loss was more prominent in the pars opercu-
laris and extended into the left basal ganglia. Damage to the network of brain
regions involved in both coordination and execution of speech causes mutism in
PNFA.
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Primary progressive aphasia (PPA) is characterized
by speech and language deficits that remain isolated
for at least 2 years.1 Once thought a unitary syn-
drome, PPA is now typically divided into variants.2,3.
Progressive nonfluent aphasia (PNFA) is character-
ized by effortful speech, agrammatism in production
and comprehension, with preserved single word com-
prehension. It has been shown that apraxia of speech
(AOS) is the most common motor speech deficit in
PNFA.2
“Mutism,” resulting from AOS or dysarthria, is
the absence of speech or articulatory movement and
can occur with neurologic disturbances, including
Parkinson disease, ALS, progressive supranuclear
palsy (PSP), and frontotemporal dementia.4 Whereas
mutism typically occurs at the end stage of dementia
of any cause, in PNFA, patients can become function-
ally mute early in the disease course, while other
cognitive functions are spared.
Previous studies consistently indicate the left pos-
terior inferior frontal (operculum) and anterior insu-
lar regions as the crucial sites of anatomic damage in
PNFA.2,5 However, the anatomic basis of early mut-
ism in these disorders is not known.
We used voxel-based morphometry (VBM) to com-
pare patterns of gray matter atrophy between pa-
tients with PNFA who developed mutism early in
the disease, non-mute patients with PNFA, and nor-
mal control subjects. We sought to identify which
brain regions are associated with early complete loss
of speech in PNFA.
Methods. Subjects and cognitive data. Six mute patients (five
women, one man) were selected from a pool of patients with PNFA
at the University of California (UCSF) Memory and Aging Center,
along with five other non-mute patients with PNFA (all women),
who presented with speech deficits of varying severity. The two
groups were matched for disease duration. PNFA was diagnosed
based on clinical history, neurologic examination, neuropsycholog-
ical screening, neuroimaging findings, and speech and language
evaluation (table). Specifically, patients presented with a motor
speech impairment and at least one of the following: agramma-
tism in language production; spared single-word comprehension
and impaired comprehension of complex syntactic structures
(table). A diagnosis of “functional mutism” was made if the patient
was unable to speak a single intelligible word owing to motor
speech impairment. All mute patients also demonstrated severe
buccofacial apraxia, and one had mild swallowing troubles. Three
of the five non-mute patients also showed buccofacial apraxia.
Forty age- and sex-matched healthy subjects, with no history
of neurologic or psychiatric disease, were used as controls for the
VBM analysis (mean age: 65.1; 6 men, 34 women). Ten age- and
sex-matched healthy subjects were used as a control group for the
cognitive data when normative data were not available (table).
Group differences were determined using the Mann–Whitney U
test. PNFA-mute patients were older than the PNFA non-mute
group (p  0.02); however, disease duration did not significantly
differ, nor did education or female-to-male ratio.
MRI scanning and VBM. MRI scans were obtained on a 1.5-T
Magnetom VISION system (Siemens Inc., Iselin, N.J.). A volumet-
ric magnetization prepared rapid gradient echo MRI (MPRAGE)
sequence was used to obtain T1-weighted images of the entire
brain, with 1.0  1.0 mm2 in-plane resolution and 1.5 mm slab
thickness. All scans were acquired within a 6-month period from
the time of clinical evaluation.
We compared gray matter regional volumes in the two groups
of patients with PNFA (mute and non-mute) using VBM standard
technique implemented in the SPM2 software package.6 Ad-hoc
age-matched a priori and template images were created. Age, gen-
der, and total intracranial volume were entered into the design
matrix as nuisance variables.
We performed specific statistical analyses to investigate the
regions of common atrophy in PNFA-mute and PNFA-non-mute vs
controls and the group differences between the two patient popu-
Additional material related to this article can be found on the Neurology
Web site. Go to www.neurology.org and scroll down the Table of Con-
tents for the November 28 issue to find the title link for this article.
Editorial, see page 1738
See also page 1752
This article was previously published in electronic format as an Expedited
E-Pub on August 23, 2006, at www.neurology.com.
From the Department of Neurology, University of California at San
Francisco.
Supported by the National Institute of Neurological Disorders and Stroke
(R01 NS050915), the State of California (DHS 04-35516), the National
Institute on Aging (P50 AG03006, P01 AG019724), the John Douglas
French Alzheimer’s Foundation, the McBean Foundation, the Sandler
Foundation, the AD Research Center of California (03-75271 DHS/ADP/
ARCC), the Larry Hillblom Foundation (grant 2002/2F), and the Koret
Foundation (grant 99-0102).
Disclosure: The authors report no conflicts of interest.
Received January 17, 2006. Accepted in final form June 19, 2006.
Address correspondence and reprint requests to Dr. M.L. Gorno-Tempini,
UCSF Department of Neurology, Memory and Aging Center, 350 Parnassus
Ave., Suite 800, Box 1207, San Francisco, CA 94143-1207; e-mail: marilu@
memory.ucsf.edu
Copyright © 2006 by AAN Enterprises, Inc. 1849
lations using the inclusive masking procedure. We accepted a
statistical threshold of p  0.05 corrected for multiple compari-
sons for the main contrasts and of p  0.001 uncorrected for the
contrasts used as masks. Based on previous work, the left inferior
frontal gyrus, anterior insula, and basal ganglia were considered a
priori regions of interest.
Results. Common atrophy in non-mute and mute. The
left inferior frontal gyrus pars opercularis, insula, supe-
rior temporal gyrus, and precentral regions were atro-
phied in mute and non-mute patients. As shown in the
figure (A through C) and table E-1 on the Neurology Web
site (www.neurology.org), the medial portion of the oper-
culum and the anterior insula regions were included in
the same cluster and, with a 12-mm smoothing kernel, it
was difficult to establish which of the two regions was
more involved. The peak coordinate (46, 13, 4) is cen-
tered in the medial portion of the frontal operculum; at a
lower threshold, the cluster extends medially and as-
sumes the shape of the insula. This region was signifi-
cantly atrophied in both groups but showed greater
volume loss in the mute group.
Greater atrophy in mute vs non-mute and control subjects.
In the mute group, atrophy was more significant and
encompassed a larger and more lateral portion of the left
inferior frontal gyrus, extending further laterally in the
pars opercularis (p  0.05 corrected for multiple compari-
son) (figure; table E-2). At a lower threshold of p  0.001
uncorrected, atrophy also extended to the left basal gan-
glia and to the pars orbitalis.
Discussion. We sought to delineate which brain
regions show greater atrophy in mute patients with
PNFA compared to patients with PNFA and milder
articulation deficits. In all patients with PNFA, sig-
nificant atrophy was found in brain regions support-
ing speech production, specifically the left inferior
frontal gyrus, insula, and superior temporal gyrus.
In the six mute patients with PNFA, however, dam-
age to this network was more extensive, with greater
atrophy noted in the left pars opercularis of the infe-
rior frontal gyrus (posterior portion of Broca area).
Atrophy in the mute cohort also extended subcorti-
cally into the left basal ganglia and thalamus and
anteriorly and ventrally to the orbitofrontal region.
The inferior frontal and insular regions areas at-
rophied in all patients with PNFA are recognized as
important for generating speech.7,8 In the mute pa-
tients, atrophy was more significant and more exten-
sive in the lateral portion of the pars opercularis of
Broca area and extended medially to encompass the
basal ganglia. Our results support roles for the ante-
rior insula and inferior frontal gyrus in speech pro-
duction, most probably in coordinating and planning
movements for speech articulation. However, signifi-
cant damage to the lateral portion of the frontal
operculum appears to be critical for causing complete
loss of speech in PNFA, most likely by supporting
the final execution stages of speech production. Fur-
thermore, in the mute group, atrophy also encom-
passed the basal ganglia, although at a lower level of
significance. The basal ganglia are thought to play a
critical role in generating motor programs for
speech.9 Therefore, in PNFA, mutism occurs when
damage to the speech production network reaches a
critical point, involving both cortical and subcortical
motor speech mechanisms.
The pattern of anatomic damage suggests that the
PFA non-mute and mute groups represent two
stages or two presentations of the same disease.
Clinical and neuropathologic data imply that cortico-
basal degeneration (CBD) and PSP are the most
common clinical evolution and pathologic diagnosis
in PNFA.5,10 This is especially true for cases in which
progressive speech disorder is the most salient
symptom.
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Table Demographic and cognitive data for mute and non-mute patients
Mute, n  6 Nonmute, n  5
Raw score (SD) Normative rating Raw score (SD) Normative rating
Age, y 69.2 (8.2)* 62.4 (9.5)
Age at onset, y 64.8 (6.8) 58.0 (9.8)
Years from first symptom 4.5 (2.1) 4.3 (2.1)
MMSE (max  30)† 26.8 (1.3) Impaired 29.2 (0.8)* Average
Modified Rey-O Copy (max  17) 14.7 (1.9) Average 15.0 (1.4) Average
Modified Rey-O Delay (max  17) 11.5 (2.3) Average 11.4 (1.5) Average
CVLT-MS (max  9) 10’ Free Recall 6.5 (2.3) Average 8.0 (0.7) Average
Design Fluency (5-Point Fluency) 5.7 (3.3) Average 7.4 (1.5) Average
Apraxia of Speech rating (0  no deficit, 7  most severe) 5.3 (2.4) Impaired 1.75 (1.5)* Impaired
Dysarthria rating (0  no deficit, 7  most severe) 4.5 (2.0) Impaired 1.0 (1.4)* Impaired
WAB word recognition (60) 59.8 (0.4) Average 60 (0) Average
Pyramid and Palm Trees (52) 49.2 (1.9) Average 51 (1.7) Average
WAB sequential commands (80) 70.4 (6.9) Impaired 76.5 (4.9) Impaired
* Groups differ at p  0.05.
† Written responses.
MMSE  Mini-Mental State Examination; CVLT-MS  The California Verbal Learning Test-Mental Status Version; WAB  Western aphasia battery.
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Figure. Areas of atrophy in mute patients vs control subjects (A) and non-mute patients vs control subjects (B) (simple
main effects). Area of common atrophy in mute and non-mute patients vs control subjects (C) and areas of greater atrophy
in mute vs non-mute patients and control subjects (D). Atrophy maps are displayed on the three-dimensional rendering of
the Montreal Neurologic Institute standard brain and on sections of the customized template image used for normaliza-
tion. Results are displayed at p  0.001 uncorrected for multiple comparisons.
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